FGFR1 and mesenchymal cell neoplasm: Half of phosphaturic mesenchymal tumors lack FGFR1 fusions; however, Klotho-β overexpression in this subset has suggested that in the absence of FGFR1 fusion, FGFR signaling is still active through Klotho-β [254].